181 related articles for article (PubMed ID: 26493349)
1. MMSA-1 expression pattern in multiple myeloma and its clinical significance.
Meng S; Lu C; Zhang W; Shen W; Wei Y; Su D; Zhou F
Clin Exp Med; 2016 Nov; 16(4):599-609. PubMed ID: 26493349
[TBL] [Abstract][Full Text] [Related]
2. Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.
He R; Yang N; Zhang P; Liu J; Li J; Zhou F; Zhang W
Oncol Rep; 2017 Jun; 37(6):3235-3243. PubMed ID: 28498418
[TBL] [Abstract][Full Text] [Related]
3. [The research on the expression and localization of multiple myeloma associated antigen MMSA-1].
Meng S; Zhou FL; Zhang WG; Cao XM; Wang BY; Wang Y; Bai GG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):63-6. PubMed ID: 22230506
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinical significance of beta-catenin in multiple myeloma].
Li J; Zhang DB; Luo SK; Zhao Y; Huang BH; Gu JL
Ai Zheng; 2007 Sep; 26(9):1010-4. PubMed ID: 17927863
[TBL] [Abstract][Full Text] [Related]
5. [Expression and Clinical Significance of MMSA-8 and MMSA-1 in Bone Marrow of Patients with M2 Acute Myeloid Leukemia].
Liang Y; Yang AY; Liu M; Cheng YJ; Zang SB; Huang J; Tang YY; Huang ZP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1018-1021. PubMed ID: 35981356
[TBL] [Abstract][Full Text] [Related]
6. The Expression of Actin-Related Protein 2/3 Complex Subunit 5 (ARPC5) Expression in Multiple Myeloma and its Prognostic Significance.
Xiong T; Luo Z
Med Sci Monit; 2018 Sep; 24():6340-6348. PubMed ID: 30201948
[TBL] [Abstract][Full Text] [Related]
7. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
Wang W; Xie Y; Han X; Liu Y; Li P
Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
[TBL] [Abstract][Full Text] [Related]
8. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma.
Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki K; Niniraki M; Stathopoulos E
Am J Clin Oncol; 2004 Feb; 27(1):8-13. PubMed ID: 14758126
[TBL] [Abstract][Full Text] [Related]
10. [Expression of
Wang YR; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):769-776. PubMed ID: 37356938
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclooxygenase-2 in multiple myeloma: association with reduced survival.
Cetin M; Buyukberber S; Demir M; Sari I; Sari I; Deniz K; Eser B; Altuntas F; Camci C; Oztürk A; Turgut B; Vural O; Unal A
Am J Hematol; 2005 Nov; 80(3):169-73. PubMed ID: 16247750
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of B cell-activating factor of TNF family (BAFF) and B cell lymphoma/leukemia-2 (BCL-2) in multiple myeloma].
Wang SM; Zhang TL; Jiang YM; Wu HY; Hao LM; Xing XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):395-8. PubMed ID: 21518495
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Clinical Significance of C/EBPα Gene in Elderly Multiple Myeloma].
Zang YZ; Chen XL; Bai YL; Zhang WH; Yu RH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):123-128. PubMed ID: 30738458
[TBL] [Abstract][Full Text] [Related]
14. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
15. [Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis].
Zhou FL; Zhang WG; Chen G; Zhao WH; Cao XM; Chen YX; Tian W; Liu SH; Wu MX; Liu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):252-7. PubMed ID: 16638191
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
Himani B; Meera S; Abhimanyu S; Usha R
Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
[TBL] [Abstract][Full Text] [Related]
18. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase production and release in a newly established human myeloma cell line.
Hatakeyama N; Daibata M; Nemoto Y; Ohtsuki Y; Taguchi H
Am J Hematol; 2001 Apr; 66(4):267-73. PubMed ID: 11279638
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
Liu JR; Luo SK; Li J; Su C
Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
